SCHEMBL23429685

SCHEMBL23429685

CCCNC(=O)CCC(C)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.53
CASP2 P42575 1/20 0.42
MCL1 Q07820 1/20 0.42
CNR1 P21554 2/20 0.41
NAAA Q02083 1/20 0.40
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 1/20 0.40
MMP12 P39900 1/20 0.40
MMP14 P50281 1/20 0.40
FAAH O00519 4/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
CHRNA4 P43681 1/20 0.38
KMT2A Q03164 2/20 0.37
GAA P10253 1/20 0.37
DNM1 Q05193 2/20 0.37
MMP1 P03956 1/20 0.36
MMP3 P08254 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19932348 0.85 CASP2 (0.65) CASP2NAAAFAAHDNM1EPHX1
SCHEMBL22175582 0.83 FAAH (0.47) ALDH1A1CASP2MCL1CNR1MMP2
SCHEMBL1518045 0.83 ALDH1A1 (0.57) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL16181357 0.82 ALDH1A1 (0.80) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL8932250 0.80 ALDH1A1 (0.53) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL21541330 0.80 ALDH1A1 (0.53) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL12059217 0.80 ALDH1A1 (0.53) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL14752354 0.79 MCL1 (0.45) ALDH1A1CASP2MCL1CNR1NAAA
SCHEMBL14983078 0.78 ALDH1A1 (0.47) ALDH1A1CASP2
SCHEMBL3351989 0.78 CASP2 (0.56) ALDH1A1CASP2MCL1CNR1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11566003-B2 Isoquinolines as inhibitors of HPK1 GENENTECH, INC. (US) 2023-01-31 US disclosed
US-20210163417-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 GENENTECH, INC. (US) 2021-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566003-B2 Isoquinolines as inhibitors of HPK1 HIPK1, HIPK2, IP6K1 ALDH1A1 4451/4885CASP2 2587/4885MCL1 98/4885
US-20210163417-A1 ISOQUINOLINES AS INHIBITORS OF HPK1 HIPK1, HIPK2, IP6K1 ALDH1A1 4451/4885CASP2 2587/4885MCL1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.